The underrepresentation of older adults in clinical trials of Janus kinase inhibitors in the treatment of atopic dermatitis.

Sreekantaswamy, Shreya A; Tully, Janell; Edelman, Linda S; Supiano, Mark A; Butler, Daniel

Sreekantaswamy, Shreya A; Tully, Janell; Edelman, Linda S; Supiano, Mark A; Butler, Daniel.

Affiliation

Sreekantaswamy SA; School of Medicine, University of Utah, Salt Lake City, Utah.
Tully J; Department of Dermatology, University of California, San Francisco, San Francisco, California; University of Arizona College of Medicine, Phoenix, Arizona.
Edelman LS; College of Nursing, University of Utah, Salt Lake City, Utah.
Supiano MA; Geriatrics Division, University of Utah, Salt Lake City, Utah.
Butler D; Department of Dermatology, University of California, San Francisco, San Francisco, California. Electronic address: Daniel.Butler@UCSF.edu.

J Am Acad Dermatol ; 87(5): 1174-1176, 2022 11.

Article de En | MEDLINE | ID: mdl-35245563

Sujet(s)
Mots clés

JAK inhibitors; atopic dermatitis; clinical trials; eczema; geriatric; older adults

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Eczéma atopique / Inhibiteurs des Janus kinases Limites: Aged / Humans Langue: En Journal: J Am Acad Dermatol Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google